Intellectual Property

With the Supreme Court's grant last week of certiorari in the Myriad Genetics case (to answer the question whether human genes isolated from the body are patentable), and the antipathy of the court, perceived by many, to patents generally, we are reminded to consider what may be the underpinnings of such antipathy.

This article requires premium access

This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.